{"transactions":[{"id":2758080,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-05T21:00:31.000Z","date":"2021-04-01","kind":"exercise","acquired":false,"shares":2315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":37037,"derivative":{"exercise_price":1.575,"expiration_date":"2028-07-19","underlying":"Common Stock","underlying_shares":2315},"source":{"system":"sec-edgar","filing":"0001209191-21-025194","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121025194/doc4.xml","form_type":"4"}},{"id":2758079,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-05T21:00:31.000Z","date":"2021-04-01","kind":"exercise","acquired":false,"shares":4629,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":4630,"derivative":{"exercise_price":1.485,"expiration_date":"2027-10-05","underlying":"Common Stock","underlying_shares":4629},"source":{"system":"sec-edgar","filing":"0001209191-21-025194","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121025194/doc4.xml","form_type":"4"}},{"id":2758078,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-04-05T21:00:31.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":6944,"price":51.4049,"value":356955.6256,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":9260,"source":{"system":"sec-edgar","filing":"0001209191-21-025194","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121025194/doc4.xml","form_type":"4"}},{"id":2758077,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-04-05T21:00:31.000Z","date":"2021-04-01","kind":"exercise","acquired":true,"shares":2315,"price":1.575,"value":3646.125,"ownership":{"direct":true},"balance_after":16204,"source":{"system":"sec-edgar","filing":"0001209191-21-025194","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121025194/doc4.xml","form_type":"4"}},{"id":2758076,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-04-05T21:00:31.000Z","date":"2021-04-01","kind":"exercise","acquired":true,"shares":4629,"price":1.485,"value":6874.065,"ownership":{"direct":true},"balance_after":13889,"source":{"system":"sec-edgar","filing":"0001209191-21-025194","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121025194/doc4.xml","form_type":"4"}},{"id":2814008,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-03T21:35:56.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":2314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":39352,"derivative":{"exercise_price":1.575,"expiration_date":"2028-07-19","underlying":"Common Stock","underlying_shares":2314},"source":{"system":"sec-edgar","filing":"0001209191-21-016880","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121016880/doc4.xml","form_type":"4"}},{"id":2814007,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-03T21:35:56.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":4630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":9259,"derivative":{"exercise_price":1.485,"expiration_date":"2027-10-05","underlying":"Common Stock","underlying_shares":4630},"source":{"system":"sec-edgar","filing":"0001209191-21-016880","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121016880/doc4.xml","form_type":"4"}},{"id":2814006,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-03-03T21:35:56.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":6944,"price":63.4405,"value":440530.832,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":9260,"source":{"system":"sec-edgar","filing":"0001209191-21-016880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121016880/doc4.xml","form_type":"4"}},{"id":2814005,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-03-03T21:35:56.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":2314,"price":1.575,"value":3644.55,"ownership":{"direct":true},"balance_after":16204,"source":{"system":"sec-edgar","filing":"0001209191-21-016880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121016880/doc4.xml","form_type":"4"}},{"id":2814004,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-03-03T21:35:56.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":4630,"price":1.485,"value":6875.55,"ownership":{"direct":true},"balance_after":13890,"source":{"system":"sec-edgar","filing":"0001209191-21-016880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121016880/doc4.xml","form_type":"4"}},{"id":2863479,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-02-12T22:00:43.000Z","date":"2020-04-03","kind":"gift","acquired":false,"shares":106481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Gift by the Reporting Person for estate planning purposes to an irrevocable trust which is managed by an independent trustee. The Reporting Person holds no voting or dispositive power over the securities held by the trust."}],"balance_after":9260,"source":{"system":"sec-edgar","filing":"0001209191-21-010195","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121010195/doc5.xml","form_type":"5"}},{"id":2863478,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-02-12T22:00:43.000Z","date":"2020-04-03","kind":"gift","acquired":false,"shares":106481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Gift by the Reporting Person for estate planning purposes to an irrevocable trust which is managed by an independent trustee. The Reporting Person holds no voting or dispositive power over the securities held by the trust."}],"balance_after":115741,"source":{"system":"sec-edgar","filing":"0001209191-21-010195","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121010195/doc5.xml","form_type":"5"}},{"id":2885853,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-02T23:00:25.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":4630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":41666,"derivative":{"exercise_price":1.575,"expiration_date":"2028-07-19","underlying":"Common Stock","underlying_shares":4630},"source":{"system":"sec-edgar","filing":"0001209191-21-006880","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121006880/doc4.xml","form_type":"4"}},{"id":2885852,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-02T23:00:25.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":2314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":13889,"derivative":{"exercise_price":1.485,"expiration_date":"2027-10-05","underlying":"Common Stock","underlying_shares":2314},"source":{"system":"sec-edgar","filing":"0001209191-21-006880","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121006880/doc4.xml","form_type":"4"}},{"id":2885851,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-02-02T23:00:25.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":6944,"price":69.9056,"value":485424.4864,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":222222,"source":{"system":"sec-edgar","filing":"0001209191-21-006880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121006880/doc4.xml","form_type":"4"}},{"id":2885850,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-02-02T23:00:25.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":4630,"price":1.575,"value":7292.25,"ownership":{"direct":true},"balance_after":229166,"source":{"system":"sec-edgar","filing":"0001209191-21-006880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121006880/doc4.xml","form_type":"4"}},{"id":2885849,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-02-02T23:00:25.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":2314,"price":1.485,"value":3436.29,"ownership":{"direct":true},"balance_after":224536,"source":{"system":"sec-edgar","filing":"0001209191-21-006880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121006880/doc4.xml","form_type":"4"}},{"id":2920830,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-05T21:40:11.000Z","date":"2020-12-01","kind":"exercise","acquired":false,"shares":6945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":16203,"derivative":{"exercise_price":1.485,"expiration_date":"2027-10-05","underlying":"Common Stock","underlying_shares":6945},"source":{"system":"sec-edgar","filing":"0001209191-21-001158","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121001158/doc4.xml","form_type":"4"}},{"id":2920829,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-01-05T21:40:11.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":6945,"price":26.3204,"value":182795.178,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":222222,"source":{"system":"sec-edgar","filing":"0001209191-21-001158","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121001158/doc4.xml","form_type":"4"}},{"id":2920828,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-01-05T21:40:11.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":6945,"price":1.485,"value":10313.325,"ownership":{"direct":true},"balance_after":229167,"source":{"system":"sec-edgar","filing":"0001209191-21-001158","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121001158/doc4.xml","form_type":"4"}},{"id":2960942,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-02T22:48:18.000Z","date":"2020-12-01","kind":"exercise","acquired":false,"shares":2315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":46296,"derivative":{"exercise_price":1.575,"expiration_date":"2028-07-19","underlying":"Common Stock","underlying_shares":2315},"source":{"system":"sec-edgar","filing":"0001209191-20-061253","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120061253/doc4.xml","form_type":"4"}},{"id":2960941,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-02T22:48:18.000Z","date":"2020-12-01","kind":"exercise","acquired":false,"shares":4630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":23148,"derivative":{"exercise_price":1.485,"expiration_date":"2027-10-05","underlying":"Common Stock","underlying_shares":4630},"source":{"system":"sec-edgar","filing":"0001209191-20-061253","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120061253/doc4.xml","form_type":"4"}},{"id":2960940,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-12-02T22:48:18.000Z","date":"2020-12-01","kind":"sale","acquired":false,"shares":6945,"price":31.5288,"value":218967.516,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":222222,"source":{"system":"sec-edgar","filing":"0001209191-20-061253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120061253/doc4.xml","form_type":"4"}},{"id":2960939,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-12-02T22:48:18.000Z","date":"2020-12-01","kind":"exercise","acquired":true,"shares":2315,"price":1.575,"value":3646.125,"ownership":{"direct":true},"balance_after":229167,"source":{"system":"sec-edgar","filing":"0001209191-20-061253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120061253/doc4.xml","form_type":"4"}},{"id":2960938,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-12-02T22:48:18.000Z","date":"2020-12-01","kind":"exercise","acquired":true,"shares":4630,"price":1.485,"value":6875.55,"ownership":{"direct":true},"balance_after":226852,"source":{"system":"sec-edgar","filing":"0001209191-20-061253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120061253/doc4.xml","form_type":"4"}},{"id":2994899,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-03T22:00:08.000Z","date":"2020-11-02","kind":"exercise","acquired":false,"shares":2315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":48611,"derivative":{"exercise_price":1.575,"expiration_date":"2028-07-19","underlying":"Common Stock","underlying_shares":2315},"source":{"system":"sec-edgar","filing":"0001209191-20-056681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120056681/doc4.xml","form_type":"4"}},{"id":2994898,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-03T22:00:08.000Z","date":"2020-11-02","kind":"exercise","acquired":false,"shares":4629,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":27778,"derivative":{"exercise_price":1.485,"expiration_date":"2027-10-05","underlying":"Common Stock","underlying_shares":4629},"source":{"system":"sec-edgar","filing":"0001209191-20-056681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120056681/doc4.xml","form_type":"4"}},{"id":2994897,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-11-03T22:00:08.000Z","date":"2020-11-02","kind":"sale","acquired":false,"shares":6944,"price":31.272,"value":217152.768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":222222,"source":{"system":"sec-edgar","filing":"0001209191-20-056681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120056681/doc4.xml","form_type":"4"}},{"id":2994896,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-11-03T22:00:08.000Z","date":"2020-11-02","kind":"exercise","acquired":true,"shares":2315,"price":1.575,"value":3646.125,"ownership":{"direct":true},"balance_after":229166,"source":{"system":"sec-edgar","filing":"0001209191-20-056681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120056681/doc4.xml","form_type":"4"}},{"id":2994895,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-11-03T22:00:08.000Z","date":"2020-11-02","kind":"exercise","acquired":true,"shares":4629,"price":1.485,"value":6874.065,"ownership":{"direct":true},"balance_after":226851,"source":{"system":"sec-edgar","filing":"0001209191-20-056681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120056681/doc4.xml","form_type":"4"}},{"id":3016433,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-02T21:19:55.000Z","date":"2020-10-01","kind":"exercise","acquired":false,"shares":2315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":50926,"derivative":{"exercise_price":1.575,"expiration_date":"2028-07-19","underlying":"Common Stock","underlying_shares":2315},"source":{"system":"sec-edgar","filing":"0001209191-20-053260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120053260/doc4.xml","form_type":"4"}},{"id":3016432,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-02T21:19:55.000Z","date":"2020-10-01","kind":"exercise","acquired":false,"shares":4630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":32407,"derivative":{"exercise_price":1.485,"expiration_date":"2027-10-05","underlying":"Common Stock","underlying_shares":4630},"source":{"system":"sec-edgar","filing":"0001209191-20-053260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120053260/doc4.xml","form_type":"4"}},{"id":3016431,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-10-02T21:19:55.000Z","date":"2020-10-01","kind":"sale","acquired":false,"shares":6945,"price":34.7504,"value":241341.528,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":222222,"source":{"system":"sec-edgar","filing":"0001209191-20-053260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120053260/doc4.xml","form_type":"4"}},{"id":3016430,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-10-02T21:19:55.000Z","date":"2020-10-01","kind":"exercise","acquired":true,"shares":2315,"price":1.575,"value":3646.125,"ownership":{"direct":true},"balance_after":229167,"source":{"system":"sec-edgar","filing":"0001209191-20-053260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120053260/doc4.xml","form_type":"4"}},{"id":3016429,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-10-02T21:19:55.000Z","date":"2020-10-01","kind":"exercise","acquired":true,"shares":4630,"price":1.485,"value":6875.55,"ownership":{"direct":true},"balance_after":226852,"source":{"system":"sec-edgar","filing":"0001209191-20-053260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120053260/doc4.xml","form_type":"4"}},{"id":3039488,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-03T20:22:33.000Z","date":"2020-09-01","kind":"exercise","acquired":false,"shares":6943,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":53241,"derivative":{"exercise_price":1.575,"expiration_date":"2028-07-19","underlying":"Common Stock","underlying_shares":6943},"source":{"system":"sec-edgar","filing":"0001209191-20-049394","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120049394/doc4.xml","form_type":"4"}},{"id":3039487,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-09-03T20:22:33.000Z","date":"2020-09-01","kind":"sale","acquired":false,"shares":6943,"price":39.1468,"value":271796.2324,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":222222,"source":{"system":"sec-edgar","filing":"0001209191-20-049394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120049394/doc4.xml","form_type":"4"}},{"id":3039486,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-09-03T20:22:33.000Z","date":"2020-09-01","kind":"exercise","acquired":true,"shares":6943,"price":1.575,"value":10935.225,"ownership":{"direct":true},"balance_after":229165,"source":{"system":"sec-edgar","filing":"0001209191-20-049394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120049394/doc4.xml","form_type":"4"}},{"id":3069766,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-04T21:14:06.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":1851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":60184,"derivative":{"exercise_price":1.575,"expiration_date":"2028-07-19","underlying":"Common Stock","underlying_shares":1851},"source":{"system":"sec-edgar","filing":"0001209191-20-044748","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120044748/doc4.xml","form_type":"4"}},{"id":3069765,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-04T21:14:06.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":9259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":37037,"derivative":{"exercise_price":1.485,"expiration_date":"2027-10-05","underlying":"Common Stock","underlying_shares":9259},"source":{"system":"sec-edgar","filing":"0001209191-20-044748","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120044748/doc4.xml","form_type":"4"}},{"id":3069764,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-08-04T21:14:06.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":11110,"price":47.6511,"value":529403.721,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."}],"balance_after":222222,"source":{"system":"sec-edgar","filing":"0001209191-20-044748","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120044748/doc4.xml","form_type":"4"}},{"id":3069763,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-08-04T21:14:06.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":1851,"price":1.575,"value":2915.325,"ownership":{"direct":true},"balance_after":233332,"source":{"system":"sec-edgar","filing":"0001209191-20-044748","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120044748/doc4.xml","form_type":"4"}},{"id":3069762,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-08-04T21:14:06.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":9259,"price":1.485,"value":13749.615,"ownership":{"direct":true},"balance_after":231481,"source":{"system":"sec-edgar","filing":"0001209191-20-044748","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120044748/doc4.xml","form_type":"4"}},{"id":3092144,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T22:43:55.000Z","date":"2020-07-01","kind":"exercise","acquired":false,"shares":49075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":62035,"derivative":{"exercise_price":1.575,"expiration_date":"2028-07-19","underlying":"Common Stock","underlying_shares":49075},"source":{"system":"sec-edgar","filing":"0001209191-20-040664","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120040664/doc4.xml","form_type":"4"}},{"id":3092143,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T22:43:55.000Z","date":"2020-07-01","kind":"exercise","acquired":false,"shares":25925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":46296,"derivative":{"exercise_price":1.485,"expiration_date":"2027-10-05","underlying":"Common Stock","underlying_shares":25925},"source":{"system":"sec-edgar","filing":"0001209191-20-040664","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120040664/doc4.xml","form_type":"4"}},{"id":3092142,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-07-02T22:43:55.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":75000,"price":37.9508,"value":2846310.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.944 to $37.956, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":222222,"source":{"system":"sec-edgar","filing":"0001209191-20-040664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120040664/doc4.xml","form_type":"4"}},{"id":3092141,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-07-02T22:43:55.000Z","date":"2020-07-01","kind":"exercise","acquired":true,"shares":49075,"price":1.575,"value":77293.125,"ownership":{"direct":true},"balance_after":297222,"source":{"system":"sec-edgar","filing":"0001209191-20-040664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120040664/doc4.xml","form_type":"4"}},{"id":3092140,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-07-02T22:43:55.000Z","date":"2020-07-01","kind":"exercise","acquired":true,"shares":25925,"price":1.485,"value":38498.625,"ownership":{"direct":true},"balance_after":248147,"source":{"system":"sec-edgar","filing":"0001209191-20-040664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120040664/doc4.xml","form_type":"4"}},{"id":3127216,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-03T01:15:55.000Z","date":"2020-06-01","kind":"exercise","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":72221,"derivative":{"exercise_price":1.485,"expiration_date":"2027-10-05","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-20-033780","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120033780/doc4.xml","form_type":"4"}},{"id":3127215,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-06-03T01:15:55.000Z","date":"2020-06-01","kind":"sale","acquired":false,"shares":75000,"price":35.2188,"value":2641410.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.2144 to $35.2245, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":222222,"source":{"system":"sec-edgar","filing":"0001209191-20-033780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120033780/doc4.xml","form_type":"4"}},{"id":3127214,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-06-03T01:15:55.000Z","date":"2020-06-01","kind":"exercise","acquired":true,"shares":75000,"price":1.485,"value":111375.0,"ownership":{"direct":true},"balance_after":297222,"source":{"system":"sec-edgar","filing":"0001209191-20-033780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120033780/doc4.xml","form_type":"4"}},{"id":3147361,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-15T23:18:19.000Z","date":"2020-05-14","kind":"exercise","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":147221,"derivative":{"exercise_price":1.485,"expiration_date":"2027-10-05","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-20-029859","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120029859/doc4.xml","form_type":"4"}},{"id":3147360,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-05-15T23:18:19.000Z","date":"2020-05-14","kind":"sale","acquired":false,"shares":75000,"price":30.0518,"value":2253885.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.0002 to $30.1521, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":222222,"source":{"system":"sec-edgar","filing":"0001209191-20-029859","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120029859/doc4.xml","form_type":"4"}},{"id":3147359,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":140541,"kind":"person","name":"Parrish Jay","position":1,"cik":"0001786372","reported_name":"Parrish Jay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-05-15T23:18:19.000Z","date":"2020-05-14","kind":"exercise","acquired":true,"shares":75000,"price":1.485,"value":111375.0,"ownership":{"direct":true},"balance_after":297222,"source":{"system":"sec-edgar","filing":"0001209191-20-029859","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120029859/doc4.xml","form_type":"4"}}]}